New Risk • Jun 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 20% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (9.4% average weekly change). Valuation Update With 7 Day Price Move • Jun 04
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CN¥40.13, the stock trades at a trailing P/E ratio of 78.3x. Average trailing P/E is 74x in the Electronic industry in China. Total returns to shareholders of 12% over the past three years. Reported Earnings • Apr 28
Full year 2025 earnings released: EPS: CN¥0.60 (vs CN¥0.59 in FY 2024) Full year 2025 results: EPS: CN¥0.60 (up from CN¥0.59 in FY 2024). Revenue: CN¥401.1m (down 5.4% from FY 2024). Net income: CN¥40.4m (up 3.2% from FY 2024). Profit margin: 10% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 8% per year. Annonce • Apr 28
Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 19, 2026 Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 19, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing China Annonce • Mar 30
Beijing Labtech Instruments Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026 Beijing Labtech Instruments Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026 Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥31.55, the stock trades at a trailing P/E ratio of 53.5x. Average trailing P/E is 58x in the Electronic industry in China. Total loss to shareholders of 27% over the past three years. Reported Earnings • Mar 01
Full year 2025 earnings released: EPS: CN¥0.59 (vs CN¥0.59 in FY 2024) Full year 2025 results: EPS: CN¥0.59 (in line with FY 2024). Revenue: CN¥402.2m (down 5.1% from FY 2024). Net income: CN¥39.4m (flat on FY 2024). Profit margin: 9.8% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 3% per year. New Risk • Feb 14
New major risk - Revenue and earnings growth Earnings have declined by 19% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 19% per year over the past 5 years. Minor Risk Dividend is not well covered by earnings (109% payout ratio). Annonce • Dec 26
Beijing Labtech Instruments Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026 Beijing Labtech Instruments Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026 Reported Earnings • Oct 28
Third quarter 2025 earnings released: EPS: CN¥0.17 (vs CN¥0.18 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.17. Revenue: CN¥92.9m (down 4.2% from 3Q 2024). Net income: CN¥11.5m (up 1.8% from 3Q 2024). Profit margin: 12% (in line with 3Q 2024). Revenue is forecast to grow 27% p.a. on average during the next 2 years, compared to a 21% growth forecast for the Electronic industry in China. Annonce • Sep 30
Beijing Labtech Instruments Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025 Beijing Labtech Instruments Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Annonce • Jun 30
Beijing Labtech Instruments Co., Ltd. to Report First Half, 2025 Results on Aug 29, 2025 Beijing Labtech Instruments Co., Ltd. announced that they will report first half, 2025 results on Aug 29, 2025 Reported Earnings • Apr 25
First quarter 2025 earnings released: EPS: CN¥0.19 (vs CN¥0.17 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.19 (up from CN¥0.17 in 1Q 2024). Revenue: CN¥99.1m (down 6.1% from 1Q 2024). Net income: CN¥12.8m (up 10% from 1Q 2024). Profit margin: 13% (up from 11% in 1Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Annonce • Apr 25
Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 16, 2025 Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 16, 2025, at 13:30 China Standard Time. Location: The Company's Meeting Room, Beijing China Valuation Update With 7 Day Price Move • Apr 14
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to CN¥35.32, the stock trades at a forward P/E ratio of 42x. Average forward P/E is 25x in the Electronic industry in China. Total returns to shareholders of 3.5% over the past three years. New Risk • Apr 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 171% Cash payout ratio: 91% Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change). Annonce • Mar 28
Beijing Labtech Instruments Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025 Beijing Labtech Instruments Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025 Reported Earnings • Feb 26
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: CN¥0.60 (up from CN¥0.41 in FY 2023). Revenue: CN¥424.4m (up 2.0% from FY 2023). Net income: CN¥39.7m (up 44% from FY 2023). Profit margin: 9.4% (up from 6.6% in FY 2023). Revenue missed analyst estimates by 11%. Earnings per share (EPS) also missed analyst estimates by 9.9%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Jan 16
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥31.63, the stock trades at a forward P/E ratio of 41x. Average forward P/E is 26x in the Electronic industry in China. Total loss to shareholders of 39% over the past three years. Annonce • Dec 27
Beijing Labtech Instruments Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025 Beijing Labtech Instruments Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025 Valuation Update With 7 Day Price Move • Dec 09
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥35.98, the stock trades at a forward P/E ratio of 47x. Average forward P/E is 26x in the Electronic industry in China. Total loss to shareholders of 45% over the past three years. Valuation Update With 7 Day Price Move • Oct 01
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to CN¥25.93, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 24x in the Electronic industry in China. Total loss to shareholders of 39% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.92 per share. Annonce • Sep 30
Beijing Labtech Instruments Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Beijing Labtech Instruments Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024 New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Annonce • Jun 28
Beijing Labtech Instruments Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024 Beijing Labtech Instruments Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024 Valuation Update With 7 Day Price Move • Jun 13
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥23.83, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 22x in the Electronic industry in China. Total loss to shareholders of 61% over the past three years. Reported Earnings • Apr 27
First quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.19 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.17 (down from CN¥0.19 in 1Q 2023). Revenue: CN¥105.5m (up 9.2% from 1Q 2023). Net income: CN¥11.6m (down 10.0% from 1Q 2023). Profit margin: 11% (down from 13% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Annonce • Apr 27
Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 17, 2024 Beijing Labtech Instruments Co., Ltd., Annual General Meeting, May 17, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing China Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥19.85, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 21x in the Electronic industry in China. Total loss to shareholders of 44% over the past three years. New Risk • Apr 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (239% cash payout ratio). Share price has been volatile over the past 3 months (10% average weekly change). Profit margins are more than 30% lower than last year (6.8% net profit margin). Annonce • Mar 29
Beijing Labtech Instruments Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Beijing Labtech Instruments Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024 Annonce • Mar 01
Beijing Labtech Instruments Co., Ltd. (SHSE:688056) announces an Equity Buyback for CNY 30 million worth of its shares. Beijing Labtech Instruments Co., Ltd. (SHSE:688056) announces a share repurchase program. Under the program, the company will repurchase up to CNY 30 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 35 per share. The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The program will be valid till 6 months. Reported Earnings • Feb 26
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: CN¥0.42 (down from CN¥0.67 in FY 2022). Revenue: CN¥415.5m (up 17% from FY 2022). Net income: CN¥28.1m (down 37% from FY 2022). Profit margin: 6.8% (down from 13% in FY 2022). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 4.9%. Earnings per share (EPS) also missed analyst estimates by 49%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. New Risk • Feb 25
New major risk - Revenue and earnings growth Earnings have declined by 6.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.6% per year over the past 5 years. Minor Risks Dividend is not well covered by cash flows (239% cash payout ratio). Profit margins are more than 30% lower than last year (9.1% net profit margin). New Risk • Feb 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (239% cash payout ratio). Share price has been volatile over the past 3 months (7.7% average weekly change). Profit margins are more than 30% lower than last year (9.1% net profit margin). Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to CN¥24.17, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 17x in the Electronic industry in China. Total loss to shareholders of 18% over the past three years. Board Change • Jan 23
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Jianming Zheng was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annonce • Dec 30
Beijing Labtech Instruments Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024 Beijing Labtech Instruments Co., Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024 Reported Earnings • Nov 01
Third quarter 2023 earnings released: EPS: CN¥0.058 (vs CN¥0.18 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.058 (down from CN¥0.18 in 3Q 2022). Revenue: CN¥103.7m (up 11% from 3Q 2022). Net income: CN¥3.83m (down 69% from 3Q 2022). Profit margin: 3.7% (down from 13% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Electronic industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 29
Second quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.15 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.15 (in line with 2Q 2022). Revenue: CN¥99.7m (up 28% from 2Q 2022). Net income: CN¥9.96m (down 2.2% from 2Q 2022). Profit margin: 10.0% (down from 13% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Electronic industry in China. Annonce • Jun 28
Beijing Labtech Instruments Co., Ltd. to Report First Half, 2023 Results on Aug 29, 2023 Beijing Labtech Instruments Co., Ltd. announced that they will report first half, 2023 results on Aug 29, 2023 Reported Earnings • Apr 26
First quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.19 (up from CN¥0.18 in 1Q 2022). Revenue: CN¥96.6m (up 25% from 1Q 2022). Net income: CN¥12.9m (up 8.0% from 1Q 2022). Profit margin: 13% (down from 15% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in China. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Director Xiaoyan Kong was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.29 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.18 (down from CN¥0.29 in 3Q 2021). Revenue: CN¥93.5m (up 7.9% from 3Q 2021). Net income: CN¥12.4m (down 35% from 3Q 2021). Profit margin: 13% (down from 22% in 3Q 2021). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥42.80, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 19x in the Electronic industry in China. Total returns to shareholders of 4.4% over the past year. Reported Earnings • Aug 29
Second quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.29 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.15 (down from CN¥0.29 in 2Q 2021). Revenue: CN¥78.0m (down 24% from 2Q 2021). Net income: CN¥10.2m (down 48% from 2Q 2021). Profit margin: 13% (down from 19% in 2Q 2021). The decrease in margin was driven by lower revenue. Valuation Update With 7 Day Price Move • Aug 10
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥41.00, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 24x in the Electronic industry in China. Total loss to shareholders of 16% over the past year. Valuation Update With 7 Day Price Move • Jun 01
Investor sentiment improved over the past week After last week's 22% share price gain to CN¥37.06, the stock trades at a trailing P/E ratio of 37.2x. Average forward P/E is 20x in the Electronic industry in China. Total loss to shareholders of 50% over the past year. Reported Earnings • Apr 27
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: EPS: CN¥0.18 (down from CN¥0.22 in 1Q 2021). Revenue: CN¥77.5m (down 2.6% from 1Q 2021). Net income: CN¥11.9m (down 18% from 1Q 2021). Profit margin: 15% (down from 18% in 1Q 2021). Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 8.8%. Over the next year, revenue is forecast to grow 63%, compared to a 24% growth forecast for the industry in China. Reported Earnings • Feb 28
Full year 2021 earnings: EPS and revenues miss analyst expectations Full year 2021 results: EPS: CN¥1.05 (down from CN¥1.17 in FY 2020). Revenue: CN¥369.4m (up 6.0% from FY 2020). Net income: CN¥70.2m (up 7.6% from FY 2020). Profit margin: 19% (in line with FY 2020). Revenue missed analyst estimates by 100%. Earnings per share (EPS) also missed analyst estimates by 7.9%. Over the next year, revenue is forecast to grow 52%, compared to a 26% growth forecast for the industry in China. Valuation Update With 7 Day Price Move • Dec 14
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥74.44, the stock trades at a forward P/E ratio of 55x. Average forward P/E is 31x in the Electronic industry in China. Total returns to shareholders of 109% over the past year. Valuation Update With 7 Day Price Move • Nov 17
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥61.30, the stock trades at a trailing P/E ratio of 49.9x. Average forward P/E is 29x in the Electronic industry in China. Total returns to shareholders of 43% over the past year. Reported Earnings • Oct 27
Third quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.30 in 3Q 2020) The company reported a solid third quarter result with improved earnings and profit margins, although revenues were flat. Third quarter 2021 results: Revenue: CN¥86.6m (flat on 3Q 2020). Net income: CN¥19.2m (up 15% from 3Q 2020). Profit margin: 22% (up from 19% in 3Q 2020). Reported Earnings • Aug 26
Second quarter 2021 earnings released: EPS CN¥0.29 (vs CN¥0.29 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥102.6m (up 9.2% from 2Q 2020). Net income: CN¥19.6m (down 1.7% from 2Q 2020). Profit margin: 19% (down from 21% in 2Q 2020). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Aug 24
Investor sentiment improved over the past week After last week's 23% share price gain to CN¥62.66, the stock trades at a trailing P/E ratio of 50.3x. Average forward P/E is 30x in the Electronic industry in China. Valuation Update With 7 Day Price Move • Jul 19
Investor sentiment deteriorated over the past week After last week's 15% share price decline to CN¥54.36, the stock trades at a trailing P/E ratio of 43.6x. Average forward P/E is 31x in the Electronic industry in China. Valuation Update With 7 Day Price Move • May 29
Investor sentiment improved over the past week After last week's 30% share price gain to CN¥73.41, the stock trades at a trailing P/E ratio of 58.9x. Average forward P/E is 25x in the Electronic industry in China. Valuation Update With 7 Day Price Move • May 12
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥47.90, the stock trades at a trailing P/E ratio of 38.4x. Average trailing P/E is 33x in the Electronic industry in China. Reported Earnings • Apr 29
Full year 2020 earnings released: EPS CN¥1.17 (vs CN¥1.23 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: CN¥348.6m (down 8.4% from FY 2019). Net income: CN¥65.2m (up 6.3% from FY 2019). Profit margin: 19% (up from 16% in FY 2019). The increase in margin was driven by lower expenses. Is New 90 Day High Low • Mar 08
New 90-day high: CN¥41.17 The company is up 6.0% from its price of CN¥38.79 on 08 December 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is down 3.0% over the same period. Valuation Update With 7 Day Price Move • Mar 05
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥37.38, the stock is trading at a trailing P/E ratio of 30.6x, up from the previous P/E ratio of 25.5x. This compares to an average P/E of 40x in the Electronic industry in China. Is New 90 Day High Low • Jan 07
New 90-day low: CN¥28.97 The company is down 20% from its price of CN¥36.35 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 7.0% over the same period. Is New 90 Day High Low • Dec 16
New 90-day low: CN¥35.08 The company is down 13% from its price of CN¥40.40 on 17 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Medical Equipment industry, which is up 4.0% over the same period. Valuation Update With 7 Day Price Move • Nov 19
Market bids up stock over the past week After last week's 20% share price gain to CN¥44.99, the stock is trading at a trailing P/E ratio of 39.7x, up from the previous P/E ratio of 33.2x. This compares to an average P/E of 44x in the Medical Equipment industry in China. Annonce • Oct 20
Beijing Labtech Instruments Co., Ltd. to Report Q3, 2020 Results on Oct 26, 2020 Beijing Labtech Instruments Co., Ltd. announced that they will report Q3, 2020 results on Oct 26, 2020